Charles E. Cooley

Array ( [id] => 8976051 [patent_doc_number] => 20130209482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'MONOCLONAL ANTIBODIES TO BASIC FIBROBLAST GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 13/327624 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10528 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016494 [patent_doc_number] => 20130231458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'POLYPEPTIDE FOR PREVENTING AND TREATING CELL HYPERPLASIA' [patent_app_type] => utility [patent_app_number] => 13/312039 [patent_app_country] => US [patent_app_date] => 2011-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2754 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13312039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280298 [patent_doc_number] => 20140030266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT' [patent_app_type] => utility [patent_app_number] => 13/989182 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29454 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838195 [patent_doc_number] => 08865871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Antibodies and kits for immunodetection of epitope tags' [patent_app_type] => utility [patent_app_number] => 13/302136 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 12190 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016322 [patent_doc_number] => 20130231286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'Use of Prolactin Receptor Antagonist and Chemotherapeutic Drug for Treating Ovarian Cancer' [patent_app_type] => utility [patent_app_number] => 13/988014 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8344 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211161 [patent_doc_number] => 20120129766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'METHODS OF TREATING FGF21-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/296343 [patent_app_country] => US [patent_app_date] => 2011-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28276 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129766.pdf [firstpage_image] =>[orig_patent_app_number] => 13296343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10906154 [patent_doc_number] => 20140309167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF ACUTE KIDNEY INJURY' [patent_app_type] => utility [patent_app_number] => 14/353236 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468994 [patent_doc_number] => 08722622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'FGF21 conjugates and anti-diabetic uses thereof' [patent_app_type] => utility [patent_app_number] => 13/289533 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 48 [patent_no_of_words] => 34408 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711821 [patent_doc_number] => 20120004173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING SKIN AGING AND SCARS' [patent_app_type] => utility [patent_app_number] => 13/233315 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5892 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13233315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353565 [patent_doc_number] => 20150238570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'THERAPEUTIC AGENT FOR HYPERTHERMIA' [patent_app_type] => utility [patent_app_number] => 14/002570 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10151 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381463 [patent_doc_number] => 20120225081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'VEGF-BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/223563 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 26334 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13223563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496725 [patent_doc_number] => 08735539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Relaxin polypeptides comprising non-naturally encoded amino acids' [patent_app_type] => utility [patent_app_number] => 13/212101 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 103938 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496725 [patent_doc_number] => 08735539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Relaxin polypeptides comprising non-naturally encoded amino acids' [patent_app_type] => utility [patent_app_number] => 13/212101 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 103938 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496725 [patent_doc_number] => 08735539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Relaxin polypeptides comprising non-naturally encoded amino acids' [patent_app_type] => utility [patent_app_number] => 13/212101 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 103938 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496725 [patent_doc_number] => 08735539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Relaxin polypeptides comprising non-naturally encoded amino acids' [patent_app_type] => utility [patent_app_number] => 13/212101 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 103938 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738281 [patent_doc_number] => 08410051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'FGF21 mutants and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/196544 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 89 [patent_no_of_words] => 32440 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13196544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670699 [patent_doc_number] => 20130045237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'Combination pharmaceutical composition and methods of treating and preventing the infectious diseases' [patent_app_type] => utility [patent_app_number] => 13/135899 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23939 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854140 [patent_doc_number] => 20130143815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'GROWTH HORMONE CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/809681 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39673 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976609 [patent_doc_number] => 20130210039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'BLOOD INSULIN RESISTANCE AND DIABETES MARKER PROGRANULIN, METHOD FOR ANALYZING CONCENTRATION OF PROGRANULIN IN BLOOD SAMPLE, AND METHOD FOR SCREENING FOR SUBSTANCE THAT IMPROVES INSULIN RESISTANCE AND IMPROVES OR SUPPRESSES DIABETES' [patent_app_type] => utility [patent_app_number] => 13/819704 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14905 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063091 [patent_doc_number] => 20110245471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'NUCLEAR FACTOR kappaB INDUCING FACTOR' [patent_app_type] => utility [patent_app_number] => 13/157798 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21137 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245471.pdf [firstpage_image] =>[orig_patent_app_number] => 13157798 [rel_patent_id] =>[rel_patent_doc_number] =>)